J Korean Neurol Assoc.
2019 Aug;37(3):235-250. 10.17340/jkna.2019.3.1.
Pharmacotherapy of Diabetes Focused on Stroke
- Affiliations
-
- 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Chosun University Hospital, Chosun University School of Medicine, Gwangju, Korea. diabetes@chosun.ac.kr
- KMID: 2454786
- DOI: http://doi.org/10.17340/jkna.2019.3.1
Abstract
- Cardiovascular disease, including stroke, is one of the major causes of death in diabetes. Numerous studies have long suggested reducing macrovascular complication such as ischemic vascular disease through intensive glycemic control, but none was successful proving the effect of glycemic control. Recently, new possibilities in cardiovascular disease reduction have been proposed through cardiovascular safety trials of newly developed anti-hyperglycemic agents. The purpose of this review is to introduce the traditional and newly developed anti-diabetic medications and review their effects regarding cardiovascular outcomes mainly focusing on stroke.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Pharmacothearpy of Adolescents with Diabetes
- 2021 Clinical Practice Guidelines for Diabetes: Pharmacotherapy and the Korean Diabetes Association Support System
- Stroke in Women: A Review Focused on Epidemiology, Risk Factors, and Outcomes
- Diabetes and Stroke
- Social Welfare Approaches for Patients with Diabetes and Stroke
